230LG, Research Associate, Cancer Immunotherapy

Job Code 230LG


Fate Therapeutics is currently seeking a motivated, conscientious, and talented individual with experience in cell culturing, flow cytometry, cloning, and gene expression to assist our immunology teams in performing and analyzing experiments involving in vitro, ex vivo, and in vivo analyses of primary and iPSC-derived CAR-T cells. This is a full-time position located at the Company’s corporate headquarters in San Diego.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 230LG.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.